Amid a season of regulatory and scientific advances, experts reveal a culture of data hoarding among cell and gene therapy ...

This CDMO insights podcast series continues with a discussion on how the complexities of gene therapies require unique technical expertise, and why early planning with the right partner can help keep ...

Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the ...

CMS’s Innovation Center plans to expand its workforce as it prepares to launch new health care payment models.

Researchers demonstrated that systemic factors from young mice can rejuvenate the aging retina by alleviating cellular senescence and restoring function.

The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce drugs such as the ALS therapy Qalsody.

One of North Carolina's largest biotechnology companies is expanding its operations with a $2 billion investment.

Scientists identify a key gene, SDR42E1, that regulates vitamin D metabolism and may unlock treatments for cancer and ...

Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...

Researchers at the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) have uncovered the ...